Literature DB >> 11741559

Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention.

M T Roe1, C B Granger, J A Puma, A S Hellkamp, J S Hochman, E M Ohman, H D White, F Van de Werf, P W Armstrong, S G Ellis, R M Califf, E J Topol.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11741559     DOI： 10.1016/s0002-9149(01)02119-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  4 in total

Review 1.  Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Lori-Ann Linkins; Antonio L Dans; Lisa K Moores; Robert Bona; Bruce L Davidson; Sam Schulman; Mark Crowther
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.

Authors:  E Marc Jolicoeur; Tracy Wang; Renato D Lopes; E Magnus Ohman
Journal:  Curr Cardiol Rep       Date:  2007-09       Impact factor: 2.931

Review 3.  Platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention: focus on the pharmacokinetic-pharmacodynamic relationships of eptifibatide.

Authors:  Ian C Gilchrist
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

4.  Intra-arterial infusion of a glycoprotein IIb/IIIa antagonist for the treatment of thromboembolism during coil embolization of intracranial aneurysm: a comparison of abciximab and tirofiban.

Authors:  H W Jeong; S-C Jin
Journal:  AJNR Am J Neuroradiol       Date:  2013-05-09       Impact factor: 3.825
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.